Finally, the results of our current study and previous studies support a representative model, which shows that JQ1/ARV-825-mediated inhibition or degradation of BET/BRD4 increases amyloidogenesis in AD (Fig. S6). This evidence concerns the gene BRD4 and Alzheimer disease.